ArticleReviews in cardiovascular medicine2024

Serum 5'-Nucleotidase as a Novel Predictor of Adverse Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease.

Mikereyi Aimaitijiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.